OBJECTIVE: Over 90% of modified LDL in circulation is associated to specific antibodies circulating as part of immune complexes (IC); however, few studies have examined their relationship with cardiovascular disease. METHODS: We report the relationship between circulating concentrations of IC of oxidized LDL (oxLDL-IC), malondialdehyde-LDL (MDA-LDL-IC) and advanced glycation end products-LDL (AGE-LDL-IC) and progression of atherosclerosis over a 12 year period in 467 individuals with type 1 diabetes who participated in the Diabetes Control and Complications Trial (DCCT) and the Epidemiology of Diabetes Interventions and Complications (EDIC) study. OxLDL-IC, AGE-LDL-IC and MDA-LDL-IC levels were measured at DCCT closeout. Internal carotid intima-medial thickness (IMT) was measured at EDIC follow-up years 1, 6 and 12. RESULTS: OxLDL-IC, AGE-LDL-IC and MDA-LDL-IC levels were significantly correlated with age, lipid levels, blood pressure levels and albumin excretion rates. Levels of oxLDL, AGE-LDL and MDA-LDL in isolated LDL-IC were highly inter-correlated (r = 0.66-0.84, P < 0.0001). After adjusting for cardiovascular risk factors individuals in the upper quartile of oxLDL-IC had a 2.98-fold increased odds (CI: 1.34, 6.62) of having IMT ≥ 1.00 mm and had a 5.13-fold increased odds (CI: 1.98, 13.3) of having significant IMT progression, relative to those in the lowest quartile. Parallel odds ratios for AGE-LDL-IC were 2.95 (CI: 1.37, 6.34) and 3.50 (CI: 1.38, 8.86), while results for MDA-LDL-IC were 1.76 (0.87, 3.56) and 2.86 (1.20, 6.81). CONCLUSION: Our study indicates that high levels of oxLDL-IC and AGE-LDL-IC are important predictors of carotid intima-medial thickening in patients with type 1 diabetes. Published by Elsevier Ireland Ltd.
OBJECTIVE: Over 90% of modified LDL in circulation is associated to specific antibodies circulating as part of immune complexes (IC); however, few studies have examined their relationship with cardiovascular disease. METHODS: We report the relationship between circulating concentrations of IC of oxidized LDL (oxLDL-IC), malondialdehyde-LDL (MDA-LDL-IC) and advanced glycation end products-LDL (AGE-LDL-IC) and progression of atherosclerosis over a 12 year period in 467 individuals with type 1 diabetes who participated in the Diabetes Control and Complications Trial (DCCT) and the Epidemiology of Diabetes Interventions and Complications (EDIC) study. OxLDL-IC, AGE-LDL-IC and MDA-LDL-IC levels were measured at DCCT closeout. Internal carotid intima-medial thickness (IMT) was measured at EDIC follow-up years 1, 6 and 12. RESULTS: OxLDL-IC, AGE-LDL-IC and MDA-LDL-IC levels were significantly correlated with age, lipid levels, blood pressure levels and albumin excretion rates. Levels of oxLDL, AGE-LDL and MDA-LDL in isolated LDL-IC were highly inter-correlated (r = 0.66-0.84, P < 0.0001). After adjusting for cardiovascular risk factors individuals in the upper quartile of oxLDL-IC had a 2.98-fold increased odds (CI: 1.34, 6.62) of having IMT ≥ 1.00 mm and had a 5.13-fold increased odds (CI: 1.98, 13.3) of having significant IMT progression, relative to those in the lowest quartile. Parallel odds ratios for AGE-LDL-IC were 2.95 (CI: 1.37, 6.34) and 3.50 (CI: 1.38, 8.86), while results for MDA-LDL-IC were 1.76 (0.87, 3.56) and 2.86 (1.20, 6.81). CONCLUSION: Our study indicates that high levels of oxLDL-IC and AGE-LDL-IC are important predictors of carotid intima-medial thickening in patients with type 1 diabetes. Published by Elsevier Ireland Ltd.
Authors: S Toshima; A Hasegawa; M Kurabayashi; H Itabe; T Takano; J Sugano; K Shimamura; J Kimura; I Michishita; T Suzuki; R Nagai Journal: Arterioscler Thromb Vasc Biol Date: 2000-10 Impact factor: 8.311
Authors: Gabriel Virella; Rickey E Carter; Antonio Saad; Edward G Crosswell; B Andrew Game; Maria F Lopes-Virella Journal: Clin Immunol Date: 2008-06 Impact factor: 3.969
Authors: S Ehara; M Ueda; T Naruko; K Haze; A Itoh; M Otsuka; R Komatsu; T Matsuo; H Itabe; T Takano; Y Tsukamoto; M Yoshiyama; K Takeuchi; J Yoshikawa; A E Becker Journal: Circulation Date: 2001-04-17 Impact factor: 29.690
Authors: Maria F Lopes-Virella; Rickey E Carter; Nathaniel L Baker; John Lachin; Gabriel Virella Journal: Nephrol Dial Transplant Date: 2011-08-19 Impact factor: 5.992
Authors: Maria F Lopes-Virella; Nathaniel L Baker; Kelly J Hunt; John Lachin; David Nathan; G Virella Journal: Atherosclerosis Date: 2010-11-17 Impact factor: 5.162
Authors: Maria F Lopes-Virella; Michael Brent McHenry; Stuart Lipsitz; Eunsil Yim; Peter F Wilson; Daniel T Lackland; Timothy Lyons; Alicia J Jenkins; Gabriel Virella Journal: Atherosclerosis Date: 2006-03-10 Impact factor: 5.162
Authors: Mohammed M Al Gadban; Kent J Smith; Farzan Soodavar; Christabelle Piansay; Charlyne Chassereau; Waleed O Twal; Richard L Klein; Gabriel Virella; Maria F Lopes-Virella; Samar M Hammad Journal: PLoS One Date: 2010-09-02 Impact factor: 3.240
Authors: Maria F Lopes-Virella; Kelly J Hunt; Nathaniel L Baker; John Lachin; David M Nathan; G Virella Journal: Diabetes Date: 2010-10-27 Impact factor: 9.461
Authors: Maria F Lopes-Virella; Nathaniel L Baker; Kelly J Hunt; Timothy J Lyons; Alicia J Jenkins; Gabriel Virella Journal: Diabetes Care Date: 2012-04-17 Impact factor: 19.112
Authors: Arpita Basu; Ionut Bebu; Alicia J Jenkins; Julie A Stoner; Ying Zhang; Richard L Klein; Maria F Lopes-Virella; W Timothy Garvey; Matthew J Budoff; Petar Alaupovic; Timothy J Lyons Journal: J Lipid Res Date: 2019-06-15 Impact factor: 5.922
Authors: Maria F Lopes-Virella; Ionut Bebu; Kelly J Hunt; Gabriel Virella; Nathaniel L Baker; Barbara Braffett; Xiaoyu Gao; John M Lachin Journal: Diabetes Date: 2019-06-19 Impact factor: 9.461
Authors: Jim C Oates; Viswanathan Ramakrishnan; Paul J Nietert; J David Spence; Thomas W Fleury; Margaret Markiewicz; Dayvia L Russell; Maria F Lopes-Virella Journal: Trans Am Clin Climatol Assoc Date: 2020
Authors: Alexander N Orekhov; Yuri V Bobryshev; Igor A Sobenin; Alexandra A Melnichenko; Dimitry A Chistiakov Journal: Int J Mol Sci Date: 2014-07-21 Impact factor: 5.923
Authors: Gerd Hörl; Harald Froehlich; Ulrika Ferstl; Gerhard Ledinski; Josepha Binder; Gerhard Cvirn; Tatjana Stojakovic; Michael Trauner; Christoph Koidl; Erwin Tafeit; Karin Amrein; Hubert Scharnagl; Günther Jürgens; Seth Hallström Journal: PLoS One Date: 2016-02-03 Impact factor: 3.240